Interleukin-12: murine models of a potent antitumor agent.
Brunda
M J
MJ
Department of Oncology, Hoffmann-La Roche Inc., Nutley, New Jersey 07110, USA.
Luistro
L
L
Rumennik
L
L
Wright
R B
RB
Wigginton
J M
JM
Wiltrout
R H
RH
Hendrzak
J A
JA
Palleroni
A V
AV
D000818:Animals; D000970:Antineoplastic Agents; D017209:Apoptosis / Q000187:drug effects; D004317:Doxorubicin / Q000008:administration & dosage; D007167:Immunotherapy; D007371:Interferon-gamma / Q000502:physiology; D018664:Interleukin-12 / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000008:administration & dosage; D007694:Killer Cells, Natural / Q000276:immunology; D008546:Melanoma, Experimental / Q000628:therapy; D051379:Mice; D008817:Mice, Mutant Strains; D019001:Nitric Oxide Synthase / Q000502:physiology; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D007376:Interleukin-2; D011994:Recombinant Proteins; D018664:Interleukin-12; D004317:Doxorubicin; D007371:Interferon-gamma; D019001:Nitric Oxide Synthase